Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H13NO |
Molecular Weight | 115.1735 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OCCN1CCCC1
InChI
InChIKey=XBRDBODLCHKXHI-UHFFFAOYSA-N
InChI=1S/C6H13NO/c8-6-5-7-3-1-2-4-7/h8H,1-6H2
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Comparison of the physicochemical properties of the N-(2-hydroxyethyl) pyrrolidine, diethylamine and sodium salt forms of diclofenac. | 2001 Jul 17 |
|
Diclofenac pyrrolidine versus Ketoprofen for the relief of pain from episiotomy: a randomized controlled trial. | 2005 Oct |
|
Ex vivo study of transdermal permeation of four diclofenac salts from different vehicles. | 2007 Apr |
|
Topical diclofenac: clinical effectiveness and current uses in osteoarthritis of the knee and soft tissue injuries. | 2008 Nov |
|
Review of the pharmaceutical properties and clinical effects of the topical NSAID formulation, diclofenac epolamine. | 2008 Oct |
|
Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography. | 2009 Aug 13 |
|
In vitro cytotoxicity of benzopyranone derivatives with basic side chain against human lung cell lines. | 2010 Nov |
|
Topical nonsteroidal anti-inflammatory drugs for the treatment of pain due to soft tissue injury: diclofenac epolamine topical patch. | 2010 Nov 10 |
|
Topical diclofenac epolamine patch 1.3% for treatment of acute pain caused by soft tissue injury. | 2010 Oct |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID70183733
Created by
admin on Sat Dec 16 15:55:48 GMT 2023 , Edited by admin on Sat Dec 16 15:55:48 GMT 2023
|
PRIMARY | |||
|
100000080496
Created by
admin on Sat Dec 16 15:55:48 GMT 2023 , Edited by admin on Sat Dec 16 15:55:48 GMT 2023
|
PRIMARY | |||
|
R3D835XVCR
Created by
admin on Sat Dec 16 15:55:48 GMT 2023 , Edited by admin on Sat Dec 16 15:55:48 GMT 2023
|
PRIMARY | |||
|
220-976-3
Created by
admin on Sat Dec 16 15:55:48 GMT 2023 , Edited by admin on Sat Dec 16 15:55:48 GMT 2023
|
PRIMARY | |||
|
7060
Created by
admin on Sat Dec 16 15:55:48 GMT 2023 , Edited by admin on Sat Dec 16 15:55:48 GMT 2023
|
PRIMARY | |||
|
C104862
Created by
admin on Sat Dec 16 15:55:48 GMT 2023 , Edited by admin on Sat Dec 16 15:55:48 GMT 2023
|
PRIMARY | |||
|
2955-88-6
Created by
admin on Sat Dec 16 15:55:48 GMT 2023 , Edited by admin on Sat Dec 16 15:55:48 GMT 2023
|
PRIMARY | |||
|
C169956
Created by
admin on Sat Dec 16 15:55:48 GMT 2023 , Edited by admin on Sat Dec 16 15:55:48 GMT 2023
|
PRIMARY | |||
|
SUB06580MIG
Created by
admin on Sat Dec 16 15:55:48 GMT 2023 , Edited by admin on Sat Dec 16 15:55:48 GMT 2023
|
PRIMARY | |||
|
26883
Created by
admin on Sat Dec 16 15:55:48 GMT 2023 , Edited by admin on Sat Dec 16 15:55:48 GMT 2023
|
PRIMARY | |||
|
76288
Created by
admin on Sat Dec 16 15:55:48 GMT 2023 , Edited by admin on Sat Dec 16 15:55:48 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)